Name | Uprosertib |
Description | Uprosertib (GSK2141795) is a potent, selective Akt broad-spectrum inhibitor with IC50 values of 180/328/38 nM for Akt1/Akt2/Akt3. |
Cell Research | Cell lines are typically grown in RPMI 160 medium containing 10% FBS. Some cell lines are grown in media specified by the vendor. A 3-day proliferation assay using CellTiter-Glo is performed to measure the growth inhibition by the compounds at 0–30 μM. Cell growth is determined relative to untreated (DMSO) controls. EC50's are calculated from inhibition curves using a 4- or 6-parameter fitting algorithm in the Assay Client application.(Only for Reference) |
Kinase Assay | Selectivity profiling experiments: The lysates (5 mg of total protein each) are preincubated with 0 (DMSO control), 2.5 nM, 25 nM, 250 nM, 2.5 μM or 25 μM free compound (GSK690693 or GSK2141795) on an end-over-end shaker for 45 min at 4 °C. Subsequently, lysates are incubated with beads (coupled Akt probe or kinobeads) for 1 h at 4 °C, for both qualitative and quantitative experiments. The beads are washed with 1× CP buffer and collected by centrifugation. Bound proteins are eluted with 2× NuPAGE LDS sample buffer, and eluates are reduced and alkylated by 50 mM dithiothreitol and 55 mM iodoacetamide. |
In vitro | 方法:K562、COLO205、SKNBE2和OVCAR8细胞混合物的裂解物用0 、2.5 nM、25 nM、250 nM、2.5 μM或25 μM的游离化合物Uprosertib (GSK2141795)在4°C的端对端摇床上预孵育45分钟。随后,裂解物与珠(偶联Akt探针或kinobads)在4°C下孵育1小时,进行定性和定量实验。
结果:Uprosertib抑制kinobead结合,Akt1的IC50值为180 nM, Akt2的IC50值为328 nM, Akt3的IC50值为38 nM;Akt1的KD值为16 nM, Akt2的KD值为49 nM, Akt3的KD值为5 nM 。[1]
方法:用 10 μM Uprosertib处理 HAP1、HAP1 RNF43 KO 和 HAP1 PWWP2B KO 细胞 48 小时,并使用 MTS 测定法评估Uprosertib的抑制作用,并检测对细胞系活力的影响。
结果:Uprosertib以剂量依赖性方式降低细胞活力。[2]
方法:在存在或不存在乳酸(0-20 mM)的情况下,用uprosertib(1μM至15μM)处理HCT116和LS174T细胞系72小时,并使用SRB测定法测定生物量;在存在或不存在乳酸(10或20mM)的情况下,用uprosertib(5或10μM)处理细胞24小时,并使用Caspase-Glo 3/7测定测量细胞凋亡
结果:Uprosertib在两种细胞系中诱导剂量依赖性细胞毒性;uprosertib诱导HCT116和LS174T细胞系中caspase-3/7激活的剂量依赖性增加。[3] |
In vivo | 方法:用Uprosertib (GSK2141795)(10mg/kg/day,口服)来研究对 MKN45 异种移植模型小鼠生长的体内疗效。
结果:uprosertib 可在 3 周时显着抑制肿瘤生长,在 KMN45 异种移植模型小鼠中的抑制率为27%。[2] |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : 76 mg/mL (177.1 mM) DMSO : 65 mg/mL (151.43 mM)
|
Keywords | Uprosertib | GSK-2141795 | inhibit | GSK 795 | GSK-795 | GSK 2141795 | Akt | Inhibitor | PKB | Protein kinase B |
Inhibitors Related | Honokiol | Capivasertib | Methyl-Hesperidin | AKT Kinase Inhibitor | Artemisinin | 2,3-Butanediol | PI3K/Akt/mTOR-IN-2 | Oridonin | Ethyl gallate | SKLB-163 |
Related Compound Libraries | Inhibitor Library | Bioactive Compound Library | Anti-Cancer Active Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Anti-Aging Compound Library | Hematonosis Compound Library | Drug Repurposing Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Drug Library |